The neurochemistry of therapeutics: Levodopa pharmacodynamics in Parkinson's disease

Annals of Neurology

Volumn 49, Issue 3, 2001, Pages 285-287

  Frey, Kirk A ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; AMPHETAMINE; BENZAMIDE DERIVATIVE; CARBON 11; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; GLUTAMIC ACID; IODINE 123; LEVODOPA; METHYLPHENIDATE; METIROSINE; RACLOPRIDE; SEROTONIN;

DEGENERATIVE DISEASE; DOPAMINERGIC SYSTEM; DRUG RECEPTOR BINDING; EDITORIAL; HUMAN; LIGAND BINDING; NEUROCHEMISTRY; NEUROLOGIC DISEASE; NEUROTRANSMISSION; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ANTIPARKINSON AGENTS; BRAIN; HUMANS; LEVODOPA; PARKINSON DISEASE;

EID: 0035097982     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.62     Document Type: Editorial

References (19)

1. Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence for increased dopamine turnover
2. 2 receptor in nonhuman primates
3. 11C]raclopride in the human brain
4. SPECT imaging of striatal dopamine release after amphetamine challenge
5. Imaging synaptic neurotransmission with in vivo binding competition techniques: A critical review
6. Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates
7. 11C]raclopride: Combined PET-microdialysis studies
8. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects
9. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method
10. 2 receptors by dopamine in schizophrenia
11. Basal ganglia dopamine release in Tourette syndrome
12. Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors
13. Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects
14. 11C]raclopride and PET in normal human subjects
15. Effects of NMDA antagonism on striatal dopamine release in healthy subjects: Application of a novel PET approach
16. 11C-raclopride in normal human subjects
17. 11C]raclopride displacement and PET
18. The classification of dopamine receptors: Relationship to radioligand binding
19. 2-receptors